Wells Fargo & Co restated their hold rating on shares of RenaissanceRe (NYSE:RNR) in a research note released on Wednesday. The firm currently has a $125.00 price target on the insurance provider’s stock.

Several other research analysts also recently weighed in on RNR. Zacks Investment Research downgraded RenaissanceRe from a hold rating to a sell rating in a research note on Wednesday, October 4th. ValuEngine downgraded RenaissanceRe from a buy rating to a hold rating in a research note on Friday, October 6th. Keefe, Bruyette & Woods reiterated a hold rating and set a $136.00 price target on shares of RenaissanceRe in a research note on Monday, October 16th. Citigroup raised RenaissanceRe from a neutral rating to a buy rating and increased their price objective for the stock from $151.00 to $157.00 in a report on Thursday, November 2nd. Finally, Morgan Stanley dropped their price objective on RenaissanceRe from $144.00 to $142.00 and set an equal weight rating on the stock in a report on Thursday, November 2nd. Two analysts have rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company’s stock. The company has an average rating of Hold and a consensus price target of $146.50.

RenaissanceRe (NYSE:RNR) opened at $129.90 on Wednesday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.66 and a current ratio of 1.77. The firm has a market capitalization of $5,231.81, a price-to-earnings ratio of -20.46, a PEG ratio of 1.41 and a beta of 0.63. RenaissanceRe has a 12 month low of $116.50 and a 12 month high of $152.00.

RenaissanceRe (NYSE:RNR) last posted its quarterly earnings results on Wednesday, January 31st. The insurance provider reported $1.05 earnings per share for the quarter, topping the consensus estimate of $0.76 by $0.29. The company had revenue of $288.22 million during the quarter, compared to the consensus estimate of $227.65 million. RenaissanceRe had a negative return on equity of 7.68% and a negative net margin of 10.57%. The firm’s quarterly revenue was up 31.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.66 EPS. research analysts forecast that RenaissanceRe will post 9.72 earnings per share for the current fiscal year.

RenaissanceRe announced that its Board of Directors has initiated a share repurchase program on Friday, November 10th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the insurance provider to buy shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s board believes its stock is undervalued.

In related news, SVP Sean G. Brosnan sold 1,391 shares of the stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $135.73, for a total transaction of $188,800.43. Following the sale, the senior vice president now owns 8,405 shares of the company’s stock, valued at approximately $1,140,810.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin Odonnell sold 5,000 shares of the stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $131.65, for a total value of $658,250.00. Following the sale, the chief executive officer now directly owns 190,707 shares in the company, valued at approximately $25,106,576.55. The disclosure for this sale can be found here. Corporate insiders own 1.80% of the company’s stock.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Ameriprise Financial Inc. raised its holdings in shares of RenaissanceRe by 3.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 127,336 shares of the insurance provider’s stock valued at $17,705,000 after acquiring an additional 3,809 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of RenaissanceRe by 16.5% in the 2nd quarter. PNC Financial Services Group Inc. now owns 2,352 shares of the insurance provider’s stock valued at $327,000 after acquiring an additional 333 shares in the last quarter. Thrivent Financial For Lutherans raised its holdings in shares of RenaissanceRe by 6.4% in the 2nd quarter. Thrivent Financial For Lutherans now owns 8,200 shares of the insurance provider’s stock valued at $1,140,000 after acquiring an additional 490 shares in the last quarter. Citigroup Inc. raised its holdings in shares of RenaissanceRe by 262.5% in the 2nd quarter. Citigroup Inc. now owns 1,566 shares of the insurance provider’s stock valued at $218,000 after acquiring an additional 1,134 shares in the last quarter. Finally, Advisor Group Inc. raised its holdings in shares of RenaissanceRe by 981.3% in the 2nd quarter. Advisor Group Inc. now owns 3,698 shares of the insurance provider’s stock valued at $514,000 after acquiring an additional 3,356 shares in the last quarter. 92.91% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “RenaissanceRe (RNR) Earns “Hold” Rating from Wells Fargo & Co” was reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.watchlistnews.com/renaissancere-rnr-earns-hold-rating-from-wells-fargo-co/1841697.html.

RenaissanceRe Company Profile

RenaissanceRe Holdings Ltd. provides reinsurance and insurance coverages and related services to a range of customers. The Company’s products include property, casualty and specialty reinsurance and certain insurance products principally distributed through intermediaries. Its segments include Property; Casualty and Specialty, and Other category.

Analyst Recommendations for RenaissanceRe (NYSE:RNR)

Receive News & Ratings for RenaissanceRe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenaissanceRe and related companies with MarketBeat.com's FREE daily email newsletter.